Novartis AG (NVS) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Novartis AG (NVS) over the last 10 years. The current PE ratio for Novartis AG as of August 22, 2017 is 17.70.
|Medical||Large Cap Pharmaceutical||$196.392B||$48.518B|
|Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.|